DE69923348D1 - Transdermales arzneistoffverabreichungssystem - Google Patents

Transdermales arzneistoffverabreichungssystem

Info

Publication number
DE69923348D1
DE69923348D1 DE69923348T DE69923348T DE69923348D1 DE 69923348 D1 DE69923348 D1 DE 69923348D1 DE 69923348 T DE69923348 T DE 69923348T DE 69923348 T DE69923348 T DE 69923348T DE 69923348 D1 DE69923348 D1 DE 69923348D1
Authority
DE
Germany
Prior art keywords
administration system
medicine administration
transdermal medicine
transdermal
dissolved
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69923348T
Other languages
English (en)
Other versions
DE69923348T9 (de
DE69923348T2 (de
Inventor
Cecil Solomon
Biljana Tocili
Louis Solomon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
DERMATECH LTD., LONDON, GB
Original Assignee
DERMATECH Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by DERMATECH Ltd filed Critical DERMATECH Ltd
Publication of DE69923348D1 publication Critical patent/DE69923348D1/de
Application granted granted Critical
Publication of DE69923348T2 publication Critical patent/DE69923348T2/de
Publication of DE69923348T9 publication Critical patent/DE69923348T9/de
Active legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
DE69923348T 1998-12-24 1999-11-17 Transdermales arzneistoffverabreichungssystem Active DE69923348T9 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9828480 1998-12-24
GBGB9828480.5A GB9828480D0 (en) 1998-12-24 1998-12-24 Transdermal drug delivery system
PCT/GB1999/003811 WO2000038659A1 (en) 1998-12-24 1999-11-17 Transdermal drug delivery system

Publications (3)

Publication Number Publication Date
DE69923348D1 true DE69923348D1 (de) 2005-02-24
DE69923348T2 DE69923348T2 (de) 2006-04-06
DE69923348T9 DE69923348T9 (de) 2006-08-10

Family

ID=10844919

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69923348T Active DE69923348T9 (de) 1998-12-24 1999-11-17 Transdermales arzneistoffverabreichungssystem

Country Status (18)

Country Link
US (1) US20050287195A1 (de)
EP (1) EP1140038B1 (de)
JP (1) JP2002533384A (de)
KR (1) KR100624235B1 (de)
AT (1) ATE287262T1 (de)
AU (1) AU756975B2 (de)
CA (1) CA2356391C (de)
DE (1) DE69923348T9 (de)
ES (1) ES2235533T3 (de)
GB (2) GB9828480D0 (de)
HU (1) HUP0104803A3 (de)
IL (2) IL143925A0 (de)
NZ (1) NZ513051A (de)
PL (1) PL194291B1 (de)
PT (1) PT1140038E (de)
WO (1) WO2000038659A1 (de)
YU (1) YU45301A (de)
ZA (1) ZA200106020B (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8529807B2 (en) * 2002-01-17 2013-09-10 Lts Lohmann Therapie-Systeme Ag Method for neutralizing or recycling carrier materials for film-like coatings
CA2494915C (en) * 2002-08-09 2012-07-10 Teikoku Seiyaku Co., Ltd. Female hormone-containing patch
JP5027373B2 (ja) * 2002-08-09 2012-09-19 帝國製薬株式会社 エストラジオール含有貼付剤
MEP25008A (en) * 2004-04-29 2010-10-10 Caldwell Galer Inc Topical methadone compositions and methods for using the same
US8936825B2 (en) * 2010-09-23 2015-01-20 Monosol Rx, Llc Method and system for forming a pharmaceutical product directly onto a packaging surface
CA2856520C (en) 2011-11-23 2021-04-06 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
WO2014188329A2 (en) * 2013-05-20 2014-11-27 Mylan, Inc. Transdermal therapeutic system for extended dosing of pramipexole in treating neurological disorders
MX2016014281A (es) 2014-05-22 2017-02-22 Therapeuticsmd Inc Formulaciones y terapias de reemplazo de combinación de hormonas naturales.
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
WO2017173044A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd Inc. Steroid hormone compositions in medium chain oils
WO2017173071A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd, Inc. Steroid hormone pharmaceutical composition
US20210000754A1 (en) * 2019-07-02 2021-01-07 Clifford T. Rowley Transdermal patch providing improved permeability and composition

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4588580B2 (en) * 1984-07-23 1999-02-16 Alaz Corp Transdermal administration of fentanyl and device therefor
JPS62106013A (ja) * 1985-10-31 1987-05-16 Kowa Co 外用投与用組成物
JPH0794394B2 (ja) * 1986-12-24 1995-10-11 前田薬品工業株式会社 消炎鎮痛外用貼付剤
HU203285B (en) * 1988-02-01 1991-07-29 Egyt Gyogyszervegyeszeti Gyar Method for producing transdermal preparation containing vegetable extract
US4906475A (en) * 1988-02-16 1990-03-06 Paco Pharmaceutical Services Estradiol transdermal delivery system
WO1991017752A1 (fr) * 1990-05-17 1991-11-28 Hisamitsu Pharmaceutical Co., Inc. Preparation a administration percutanee, contenant de l'×stradiol
GB9021674D0 (en) * 1990-10-05 1990-11-21 Ethical Pharma Ltd Transdermal device
US5152997A (en) * 1990-12-11 1992-10-06 Theratech, Inc. Method and device for transdermally administering testosterone across nonscrotal skin at therapeutically effective levels
US5164190A (en) * 1990-12-11 1992-11-17 Theratech, Inc. Subsaturated transdermal drug delivery device exhibiting enhanced drug flux
JP2960832B2 (ja) * 1992-05-08 1999-10-12 ペルマテック テクノロジー アクチェンゲゼルシャフト エストラジオールの投与システム
GB2273044B (en) * 1992-12-02 1997-04-09 Pacific Chem Co Ltd Medicinal patches for percutaneous administration
JPH09208469A (ja) * 1996-02-02 1997-08-12 Mikasa Seiyaku Kk 経皮吸収貼付剤
AUPN814496A0 (en) * 1996-02-19 1996-03-14 Monash University Dermal penetration enhancer
IT1283102B1 (it) * 1996-06-06 1998-04-07 Permatec Nv Composizione terapeutica per la somministrazione transdermica di un principio attivo estrogeno o progestinico o di loro miscele
US5985317A (en) * 1996-09-06 1999-11-16 Theratech, Inc. Pressure sensitive adhesive matrix patches for transdermal delivery of salts of pharmaceutical agents

Also Published As

Publication number Publication date
AU1067800A (en) 2000-07-31
PL349077A1 (en) 2002-07-01
EP1140038A1 (de) 2001-10-10
DE69923348T9 (de) 2006-08-10
IL143925A (en) 2006-06-11
AU756975B2 (en) 2003-01-30
US20050287195A1 (en) 2005-12-29
ZA200106020B (en) 2002-02-28
PL194291B1 (pl) 2007-05-31
GB2345246A (en) 2000-07-05
YU45301A (sh) 2004-05-12
HUP0104803A2 (hu) 2002-05-29
DE69923348T2 (de) 2006-04-06
KR100624235B1 (ko) 2006-09-13
KR20010093223A (ko) 2001-10-27
GB2345246B (en) 2001-07-25
CA2356391A1 (en) 2000-07-06
WO2000038659A1 (en) 2000-07-06
GB9927038D0 (en) 2000-01-12
EP1140038B1 (de) 2005-01-19
IL143925A0 (en) 2002-04-21
CA2356391C (en) 2006-10-10
GB9828480D0 (en) 1999-02-17
JP2002533384A (ja) 2002-10-08
ES2235533T3 (es) 2005-07-01
ATE287262T1 (de) 2005-02-15
PT1140038E (pt) 2005-04-29
NZ513051A (en) 2002-12-20
HUP0104803A3 (en) 2006-07-28

Similar Documents

Publication Publication Date Title
DE69923348D1 (de) Transdermales arzneistoffverabreichungssystem
ATE288743T1 (de) Pharmazeutische trägervorrichtung welche zur verabreichung von wirkstoffen an schleimhautoberflächen geeignet ist
DK0973497T3 (da) Farmaceutisk bæreanordning, egnet til udlevering af farmaceutiske forbindelser til slimhindeoverflade
ATE238778T1 (de) Transdermales therapeutisches system zur abgabe von hormonen
DE69916492D1 (de) Pflaster zur transdermalen applikation von flüchtigen, flüssigen wirkstoffen
ATE163854T1 (de) Dexpanthenol-haltiges pflaster zur transdermalen applikation von steroidhormonen
DE59308413D1 (de) Pflaster zur transdermalen verabreichung von flüchtigen, pharmazeutisch wirksamen, chemisch basischen inhaltsstoffen und verfahren zu seiner herstellung
ATE396714T1 (de) Transdermales therapeutisches system mit verbessertem langzeittragekomfort
DE50100870D1 (de) Transdermales therapeutisches system zur verabreichung von zaleplon
DE69706070T2 (de) Zubereitung zur perkutanen verabreichung enthaltend 6-amino-5-chloro-1-isopropyl-2-(4-methyl-1-piperazinyl)benzimidazol
PT1011674E (pt) Sistema terapeutico transdermico com a substancia activa escopolamina base
ES2141548T3 (es) Preparado farmaceutico de superficie estabilizada para su aplicacion sobre la piel.
ES2188021T3 (es) Metodo para evitar el uso indebido de un sistema terapeutico percutaneo.
KR960021014A (ko) 키토산을 이용한 매트릭스형 경피흡수제제 및 그 제조방법
YU71293A (sh) Transdermalni terapijski sistem za davanje fizostigmina na koži i postupak za njegovu izradu
DE3770836D1 (de) Dermale und transdermale therapeutische systeme mit musterfoermig aufgetragener klebschicht, sowie verfahren zur dessen herstellung.
NO924926L (no) Transdermal administrering av buprenorfin
MX9707868A (es) La triacetina como incrementador de penetracion transdermica.
CA2144441A1 (en) Dexpanthenol-containing plaster for the transdermal application of steroid hormones

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: MATRIX TRANSDERMAL SYSTEMS LTD., TORTOLA, VG

8328 Change in the person/name/address of the agent

Representative=s name: WIESE KONNERTH FISCHER PATENTANWAELTE PARTNERSCHAF

8327 Change in the person/name/address of the patent owner

Owner name: DERMATECH LTD., LONDON, GB